Products Direct oral anticoagulants (abbreviation: DOAKs) are commercially available in the form of film-coated tablets and capsules. By definition, they are oral drugs. Some representatives of the corresponding drug groups are also available as infusion preparations. Rivaroxaban (Xarelto) and dabigatran (Pradaxa) were the first active ingredients to be approved in 2008. The DOAKs were developed … DOAK
Introduction Xarelto® is a trade name for the active ingredient rivaroxaban. This is an anticoagulation drug, colloquially a blood thinner. The family doctor treating you will closely monitor your intake and should not stop taking it without his instructions. However, discontinuation of Xarelto® is necessary under certain circumstances. This should also only be done on … What should be observed when weaning Xarelto®?
Is bridging necessary? Bridging is the interruption of the intake of medication for a short period of time. This may be necessary with anticoagulants before operations. Small operations, such as dental surgery, can be performed without bridging. Larger operations, however, are associated with a high risk of bleeding and therefore cannot be carried out while … Is bridging necessary? | What should be observed when weaning Xarelto®?
